 |
InterPro: IPR001245 Tyrosine-protein kinase, catalytic domain
Protein matches
|
UniProtKB Matches: 8271 proteins |
|
Accession
|
IPR001245 Tyr_prot_kinase_cat_dom |
Type
|
Domain |
Signatures
|
|
InterPro Relationships
|
|
Parent
|
IPR000719 Protein kinase, catalytic domain
|
|
Children
|
IPR015783 ATMRK serine/threonine protein kinase-like
IPR020635 Tyrosine-protein kinase, subgroup, catalytic domain
|
|
Found in
|
IPR009127 Tyrosine-protein kinase, JAK, conserved region
IPR009128 Tyrosine-protein kinase, JAK1
IPR009130 Tyrosine-protein kinase, JAK3
IPR009131 Tyrosine-protein kinase, non-receptor, TYK2
IPR009136 Tyrosine-protein kinase, vascular endothelial growth factor receptor 2 (VEGFR2)
IPR012234 Tyrosine-protein kinase, non-receptor SYK/ZAP-70
IPR015772 Tyrosine-protein kinase, non-receptor TNK1
IPR015773 Tyrosine-protein kinase, non-receptor MATK
IPR015774 Tyrosine-protein kinase, non-receptor PTK6
IPR015775 Tyrosine-protein kinase, receptor Axl-related
IPR015776 Tyrosine-protein kinase, platelet-derived growth factor receptor alpha
IPR015777 Tyrosine-protein kinase, Ret receptor-like
IPR015778 Tyrosine-protein kinase, non-receptor Csk
IPR015779 Tyrosine-protein kinase, non-receptor Ack, N-terminal
IPR015780 Tyrosine-protein kinase, epidermal growth factor receptor-related
IPR015781 Tyrosine-protein kinase, angiopoietin receptor
IPR015785 Mitogen activated protein kinase kinase kinase-like
IPR016243 Tyrosine-protein kinase, CSF-1/PDGF receptor
IPR016244 Tyrosine-protein kinase, HGF/MSP receptor
IPR016245 Tyrosine protein kinase, EGF/ERB/XmrK receptor
IPR016246 Tyrosine-protein kinase, insulin-like receptor
IPR016247 Tyrosine-protein kinase, receptor ROR, subgroup
IPR016248 Tyrosine-protein kinase, fibroblast growth factor receptor
IPR016249 Tyrosine-protein kinase, Ret receptor
IPR016250 Tyrosine-protein kinase, non-receptor Fes, subgroup
IPR016251 Tyrosine-protein kinase, non-receptor Jak/Tyk2
IPR016253 Integrin-linked protein kinase
IPR016257 Tyrosine-protein kinase, ephrin receptor
IPR020685 Tyrosine-protein kinase
IPR020686 Tyrosine-protein kinase, non-receptor ZAP-70
IPR020688 Tyrosine-protein kinase, receptor Let-23
IPR020689 Tyrosine-protein kinase, EGF receptor, fish
IPR020690 Tyrosine-protein kinase, receptor erbB-4
IPR020691 Tyrosine-protein kinase, receptor erbB-3, fish
IPR020692 Tyrosine-protein kinase, receptor erbB-3
IPR020693 Tyrosine-protein kinase, non-receptor Jak2
IPR020694 Tyrosine-protein kinase, ephrin receptor, subgroup
IPR020695 Tyrosine-protein kinase, receptor STYK1
IPR020696 Tyrosine-protein kinase, receptor Tie-1
IPR020697 Tyrosine-protein kinase, non-receptor ITK/TSK
IPR020698 Tyrosine-protein kinase, non-receptor Btk29A
IPR020699 Tyrosine-protein kinase, non-receptor Srms
IPR020700 Tyrosine-protein kinase, non-receptor Abl
IPR020701 Tyrosine-protein kinase, non-receptor Src-1, nematode
IPR020702 Tyrosine-protein kinase, non-receptor FRK
IPR020703 Tyrosine-protein kinase, non-receptor Src64B
IPR020704 Tyrosine-protein kinase, receptor TYRO3, Zebrafish
IPR020705 Tyrosine-protein kinase, receptor MER
IPR020706 Tyrosine-protein kinase, receptor SEA
IPR020707 Tyrosine-protein kinase, hepatocyte growth factor receptor
IPR020710 Tyrosine-protein kinase, insulin receptor
IPR020712 Tyrosine-protein kinase, insulin-related receptor
IPR020713 Tyrosine-protein kinase, insulin-like receptor, Drosphila
IPR020714 Tyrosine-protein kinase, insulin-like growth factor receptor
IPR020715 Tyrosine-protein kinase, receptor Ror2
IPR020716 Tyrosine-protein kinase, muscle/skeletal receptor
IPR020718 Tyrosine-protein kinase, PDGF/VEGF receptor, fly
IPR020720 Tyrosine-protein kinase, receptor Cad96
IPR020721 Tyrosine-protein kinase, vascular endothelial growth factor receptor 3 (VEGFR3)
IPR020722 Tyrosine-protein kinase, vascular endothelial growth factor receptor 1 (VEGFR1)
IPR020724 Tyrosine-protein kinase, receptor torso
IPR020725 Tyrosine-protein kinase, myoblast growth factor receptor Egl-15
IPR020727 Tyrosine-protein kinase, platelet-derived growth factor receptor beta
IPR020729 Tyrosine-protein kinase, macrophage colony-stimulating factor 1 receptor
IPR020730 Tyrosine-protein kinase, mast/stem cell growth factor receptor
IPR020732 Tyrosine-protein kinase, fibroblast growth factor receptor-related
IPR020733 Tyrosine-protein kinase, receptor kin-15/16
IPR020734 Tyrosine-protein kinase, FL cytokine receptor
IPR020735 Tyrosine-protein kinase, ALK receptor
IPR020736 Tyrosine-protein kinase, non-receptor Hopscotch
IPR020737 Serine/threonine-protein kinase, receptor LMTK
IPR020738 Tyrosine-protein kinase, receptor ROS/Sevenless
IPR020739 Tyrosine-protein kinase, MSP receptor
IPR020740 Tyrosine-protein kinase, receptor RYK
IPR020741 Tyrosine-protein kinase, receptor TYRO3
IPR020742 Tyrosine-protein kinase, discoidin domain-containing receptor
IPR020743 Tyrosine-protein kinase, non-receptor YES
IPR020744 Tyrosine-protein kinase, non-receptor Src
IPR020745 Tyrosine-protein kinase, non-receptor Fyn
IPR020746 Tyrosine-protein kinase, non-receptor Fgr
IPR020747 Tyrosine-protein kinase, non-receptor Lyn
IPR020748 Tyrosine-protein kinase, non-receptor Hck
IPR020749 Tyrosine-protein kinase, non-receptor Lck
IPR020750 Tyrosine-protein kinase, non-receptor Blk
IPR020753 Tyrosine-protein kinase, non-receptor Btk
IPR020755 Tyrosine-protein kinase, non-receptor Txk/Tec
IPR020757 Tyrosine-protein kinase, non-receptor SYK
IPR020760 Tyrosine-protein kinase, receptor erbB-2
IPR020762 Tyrosine-protein kinase, EGF receptor
IPR020763 Tyrosine-protein kinase, receptor ROR
IPR020764 Tyrosine-protein kinase, non-receptor Fes
IPR020766 Tyrosine-protein kinase, ephrin A10 receptor
IPR020767 Tyrosine-protein kinase, ephrin B6 receptor
IPR020768 Tyrosine-protein kinase, ephrin A receptor
IPR020769 Tyrosine-protein kinase, ephrin B receptor
IPR020770 Tyrosine-protein kinase, ephrin A1/A2 receptor
IPR020771 Tyrosine-protein kinase, non-receptor Shark
IPR020772 Tyrosine-protein kinase, receptor Daf-2
IPR020773 Tyrosine-protein kinase, non-receptor FADK
IPR020774 Tyrosine-protein kinase, receptor PTK7
IPR020775 Tyrosine-protein kinase, non-receptor Jak3
IPR020776 Tyrosine-protein kinase, non-receptor Jak1
IPR020777 Tyrosine-protein kinase, neurotrophic receptor
|
|
Contains
|
IPR001824 Tyrosine-protein kinase, receptor class III, conserved site
IPR002011 Tyrosine-protein kinase, receptor class II, conserved site
IPR008266 Tyrosine-protein kinase, active site
IPR017441 Protein kinase, ATP binding site
|
GO Term annotation
|
|
Process
|
GO:0006468 protein amino acid phosphorylation
|
|
Function
|
GO:0004713 protein tyrosine kinase activity
GO:0005524 ATP binding
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process.
Protein kinases fall into three broad classes, characterised with respect to substrate specificity [1]:
- Serine/threonine-protein kinases
- Tyrosine-protein kinases
- Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins)
Protein kinase function has been evolutionarily conserved from Escherichia coli to human [2]. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation [3]. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [4], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases [5].
Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups [2]:
- Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis [6]. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction [7].
- Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases [8].
|
Structural links
|
|
Database links
|
Pfam Clan: CL0016.18
|
Interactions
|
This domain has been experimentally proven to be involved in Protein:Protein interactions. Representative
data is shown with the following
example proteins:
|
Example proteins
|
C0LGH8 Probable LRR receptor-like serine/threonine-protein kinase At1g63430
O60674 Tyrosine-protein kinase JAK2
O61460 Ephrin receptor 1
P00520 Proto-oncogene tyrosine-protein kinase ABL1
P04412 Epidermal growth factor receptor
More proteins
Example Proteins Key
| InterPro entry accession number/name and structure databases |
Colour code |
| IPR006212 |
Furin-like repeat |
 |
| IPR020700 |
Tyrosine-protein kinase, non-receptor Abl |
 |
| IPR015015 |
F-actin binding |
 |
| IPR000299 |
FERM domain |
 |
| IPR017441 |
Protein kinase, ATP binding site |
 |
| IPR006211 |
Furin-like cysteine-rich domain |
 |
| IPR020693 |
Tyrosine-protein kinase, non-receptor Jak2 |
 |
| IPR009030 |
Growth factor, receptor |
 |
| IPR011009 |
Protein kinase-like domain |
 |
| IPR008957 |
Fibronectin, type III-like fold |
 |
| IPR009127 |
Tyrosine-protein kinase, JAK, conserved region |
 |
| IPR001611 |
Leucine-rich repeat |
 |
| IPR009129 |
Tyrosine-protein kinase, JAK2, conserved region |
 |
| IPR008979 |
Galactose-binding domain-like |
 |
| IPR000719 |
Protein kinase, catalytic domain |
 |
| IPR020635 |
Tyrosine-protein kinase, subgroup, catalytic domain |
 |
| IPR003961 |
Fibronectin, type III |
 |
| IPR001245 |
Tyrosine-protein kinase, catalytic domain |
 |
| IPR013210 |
Leucine-rich repeat-containing N-terminal domain, type 2 |
 |
| IPR019749 |
Band 4.1 domain |
 |
| IPR001452 |
Src homology-3 domain |
 |
| IPR001090 |
Ephrin receptor, ligand binding |
 |
| IPR008266 |
Tyrosine-protein kinase, active site |
 |
| IPR000494 |
EGF receptor, L domain |
 |
| IPR015780 |
Tyrosine-protein kinase, epidermal growth factor receptor-related |
 |
| IPR020685 |
Tyrosine-protein kinase |
 |
| IPR000980 |
SH2 motif |
 |
| IPR016251 |
Tyrosine-protein kinase, non-receptor Jak/Tyk2 |
 |
|
ModBase |
 |
|
SWISS-MODEL |
 |
|
PDB Chain |
 |
|
CATH Domain |
 |
|
SCOP Domain |
 |
|
Publications
|
|
1.
|
Hanks SK, Quinn AM, Hunter T.
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.
Science 241 42-52 1988
[PubMed: 3291115]
http://www.sciencemag.org/cgi/content/abstract/241/4861/42
|
|
2.
|
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S.
The protein kinase complement of the human genome.
Science 298 1912-34 2002
[PubMed: 12471243]
http://dx.doi.org/10.1126/science.1075762
|
|
3.
|
Manning G, Plowman GD, Hunter T, Sudarsanam S.
Evolution of protein kinase signaling from yeast to man.
Trends Biochem. Sci. 27 514-20 2002
[PubMed: 12368087]
http://dx.doi.org/10.1016/S0968-0004(02)02179-5
|
|
4.
|
Stout TJ, Foster PG, Matthews DJ.
High-throughput structural biology in drug discovery: protein kinases.
Curr. Pharm. Des. 10 1069-82 2004
[PubMed: 15078142]
http://dx.doi.org/10.2174/1381612043452695
|
|
5.
|
Li B, Liu Y, Uno T, Gray N.
Creating chemical diversity to target protein kinases.
Comb. Chem. High Throughput Screen. 7 453-72 2004
[PubMed: 15320712]
http://openurl.ingenta.com/content?genre=article&issn=1386-2073&volume=7&issue=5&spage=453
|
|
6.
|
Sharma PS, Sharma R, Tyagi T.
Receptor tyrosine kinase inhibitors as potent weapons in war against cancers.
Curr. Pharm. Des. 15 758-76 2009
[PubMed: 19275641]
http://dx.doi.org/10.2174/138161209787582219
|
|
7.
|
Li E, Hristova K.
Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.
Biochemistry 45 6241-51 2006
[PubMed: 16700535]
http://dx.doi.org/10.1021/bi060609y
|
|
8.
|
Roskoski R Jr.
Src kinase regulation by phosphorylation and dephosphorylation.
Biochem. Biophys. Res. Commun. 331 1-14 2005
[PubMed: 15845350]
http://dx.doi.org/10.1016/j.bbrc.2005.03.012
|
Additional Reading
|
|
Cooper JA, Hunter T.
Viral oncogene and tyrosine phosphorylation.
17 1986 191-246
|
|
Schroeder GM, Chen XT, Williams DK, Nirschl DS, Cai ZW, Wei D, Tokarski JS, An Y, Sack J, Chen Z, Huynh T, Vaccaro W, Poss M, Wautlet B, Gullo-Brown J, Kellar K, Manne V, Hunt JT, Wong TW, Lombardo LJ, Fargnoli J, Borzilleri RM.
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase.
Bioorg. Med. Chem. Lett. 18 2008 1945-51
[PubMed: 18289854]
http://dx.doi.org/10.1016/j.bmcl.2008.01.121
|
|
Cai ZW, Wei D, Schroeder GM, Cornelius LA, Kim K, Chen XT, Schmidt RJ, Williams DK, Tokarski JS, An Y, Sack JS, Manne V, Kamath A, Zhang Y, Marathe P, Hunt JT, Lombardo LJ, Fargnoli J, Borzilleri RM.
Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors.
Bioorg. Med. Chem. Lett. 18 2008 3224-9
[PubMed: 18479916]
http://dx.doi.org/10.1016/j.bmcl.2008.04.047
|
|
Hunter T, Plowman GD.
The protein kinases of budding yeast: six score and more.
Trends Biochem. Sci. 22 1997 18-22
[PubMed: 9020587]
http://dx.doi.org/10.1016/S0968-0004(96)10068-2
|
|
Levinson NM, Seeliger MA, Cole PA, Kuriyan J.
Structural basis for the recognition of c-Src by its inactivator Csk.
Cell 134 2008 124-34
[PubMed: 18614016]
http://dx.doi.org/10.1016/j.cell.2008.05.051
|
|
Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong KK, Meyerson M, Eck MJ.
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.
Proc. Natl. Acad. Sci. U.S.A. 105 2008 2070-5
[PubMed: 18227510]
http://dx.doi.org/10.1073/pnas.0709662105
|
|
Hanks SK, Hunter T.
Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.
FASEB J. 9 1995 576-96
[PubMed: 7768349]
http://www.fasebj.org/cgi/content/abstract/9/8/576
|
|
Hanks SK, Quinn AM.
Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members.
Meth. Enzymol. 200 1991 38-62
[PubMed: 1956325]
http://dx.doi.org/10.1016/0076-6879(91)00126-H
|
|
Kim KS, Zhang L, Schmidt R, Cai ZW, Wei D, Williams DK, Lombardo LJ, Trainor GL, Xie D, Zhang Y, An Y, Sack JS, Tokarski JS, Darienzo C, Kamath A, Marathe P, Zhang Y, Lippy J, Jeyaseelan R Sr, Wautlet B, Henley B, Gullo-Brown J, Manne V, Hunt JT, Fargnoli J, Borzilleri RM.
Discovery of pyrrolopyridine-pyridone based inhibitors of Met kinase: synthesis, X-ray crystallographic analysis, and biological activities.
J. Med. Chem. 51 2008 5330-41
[PubMed: 18690676]
http://dx.doi.org/10.1021/jm800476q
|
|
Lin J, Sun T, Ji L, Deng W, Roth J, Minna J, Arlinghaus R.
Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.
Oncogene 26 2007 6989-96
[PubMed: 17486070]
http://dx.doi.org/10.1038/sj.onc.1210500
|
|